A detailed history of Leeward Financial Partners, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Leeward Financial Partners, LLC holds 4,227 shares of LLY stock, worth $3.19 Million. This represents 1.42% of its overall portfolio holdings.

Number of Shares
4,227
Previous 4,072 3.81%
Holding current value
$3.19 Million
Previous $3.69 Million 1.57%
% of portfolio
1.42%
Previous 1.51%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024

BUY
$772.14 - $960.02 $119,681 - $148,803
155 Added 3.81%
4,227 $3.74 Million
Q2 2024

Jul 30, 2024

BUY
$724.87 - $909.04 $2.67 Million - $3.35 Million
3,681 Added 941.43%
4,072 $3.69 Million
Q1 2024

Apr 19, 2024

BUY
$592.2 - $792.28 $231,550 - $309,781
391 New
391 $304,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $717B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Leeward Financial Partners, LLC Portfolio

Follow Leeward Financial Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Leeward Financial Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Leeward Financial Partners, LLC with notifications on news.